TWiV 834: COVID-19 clinical update #90 with Dr. Daniel Griffin
In COVID-19 clinical update #90, Dr. Griffin covers FDA expansion for booster doses, 3 more at home antigen tests approved by FDA, immune correlates analysis of mRNA-1273 vaccine, risk for stillbirth, PROVENT prophylaxis trial results, fluvoxamine recommendations, advice on molnupiravir, automated text messaging service for monitoring illness, and long COVID-19 after vaccination and infection. Hosts: Daniel Griffin and Vincent Racaniello Subscribe (free): iTunes, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode Expanded eligibility for booster doses (FDA) More rapid antigen tests approved...
Source: This Week in Virology - MP3 Edition - November 27, 2021 Category: Virology Authors: Vincent Racaniello Source Type: podcasts
TWiV 787: COVID-19 clinical update #73 with Dr. Daniel Griffin
In COVID-19 clinical update #73, Daniel Griffin reviews updated mask guidance from CDC, infections in public school district employees, effectiveness of vaccines against delta variant, antibody response after third vaccine dose in kidney transplant recipients, protection afforded by mRNA vaccines fully vaccinated people with and without prior infections, correlates of protection in nonhuman primates, lack of effectiveness of doxycycline, neurological manifestations of COVID-19, and infection in vaccinated health care workers. Hosts: Daniel Griffin and Vincent Racaniello Subscribe (free): iTunes, Google Podcasts, RSS, ...
Source: This Week in Virology - MP3 Edition - July 31, 2021 Category: Virology Authors: Vincent Racaniello Source Type: podcasts
Effect of Doxycycline on AAA Growth, Deprescribing Antihypertensives in Older Adults, Preventing Illicit Drug Use in Adolescents, and more
Editor's Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the May 26, 2020 issue (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - May 26, 2020 Category: General Medicine Authors: JAMA Network Source Type: podcasts
ASH 2015: Oral Doxycycline Improves Outcomes of Stage III Amyloidosis - a Matched Case Control Study
Oral Doxycycline Improves Outcomes of Stage III AL Amyloidosis - a Matched Case Control Study
Dr. Ashutosh Wechalekar
National Amyloidosis Centre
University College London
London, United Kingdo...
Author: InternationalMyelomaFoundation
Added: 12/08/2015 (Source: Oncology Tube)
Source: Oncology Tube - December 8, 2015 Category: Cancer & Oncology Source Type: podcasts
Doxycycline for Rocky Mountain Spotted Fever: Safe for All Ages
New research shows that doxycycline does not cause tooth enamel defects or discoloration, and should not be withheld from young children with suspected Rocky Mountain spotted fever. (Source: Medscape Pediatrics Podcast)
Source: Medscape Pediatrics Podcast - May 26, 2015 Category: Pediatrics Authors: Medscape Source Type: podcasts
